Kristin Lundy DeMello

Title: Kristin Lundy DeMello: Innovator in Pharmaceutical Chemistry

Introduction

Kristin Lundy DeMello is a prominent inventor based in Ledyard, CT (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address inflammation and pain relief.

Latest Patents

Kristin holds 2 patents that showcase her innovative work. Her latest patents include "5-heteroatom-substituted pyrazoles," which relates to specific chemical compounds designed for medicinal use. Another notable patent is for "Selective inhibitors of cyclooxygenase-2," which focuses on compounds that selectively inhibit the COX-2 enzyme. These compounds are particularly useful in treating inflammation-related disorders, such as rheumatoid arthritis and osteoarthritis, and in alleviating pain associated with surgery or trauma in mammals, especially felines and canines.

Career Highlights

Kristin is currently associated with Pfizer Corporation, a leading global pharmaceutical company. Her work at Pfizer has allowed her to contribute to the development of important therapeutic agents that improve the quality of life for many patients.

Collaborations

Throughout her career, Kristin has collaborated with notable colleagues, including Martha L Minich and Subas Man Sakya. These collaborations have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Kristin Lundy DeMello is a dedicated inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of inflammation and pain. Her contributions continue to impact the medical community positively.